|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net Income | |||||
| Adjustments to Reconcile Net Income to Net Cash Provided by (Used In) Operating Activities: | |||||
| Net (Gains) Losses on Investments, Investment Securities and Contingent Consideration | |||||
| Equity Method Investments, Including (Gains) Losses on Sales and Redemptions | |||||
| Equity-Based and Other Deferred Compensation | |||||
| Release of Cumulative Foreign Exchange Losses | |||||
| Noncash Lease Expense | |||||
| Depreciation, Amortization and Accretion, net | |||||
| Bad Debt Expense | |||||
| Deferred Taxes | |||||
| Decrease (Increase) in Operating Assets: | |||||
| Investment Securities | |||||
| Accounts Receivable | |||||
| Receivable from Employees and Related Parties | |||||
| Other Assets | |||||
| (Decrease) Increase in Operating Liabilities: | |||||
| Accrued Compensation and Benefits | |||||
| Accounts Payable and Accrued Expenses | |||||
| Payables to Employees and Related Parties | |||||
| Taxes Payable | |||||
| Other Liabilities | |||||
| Net Cash Provided by Operating Activities | |||||
| Cash Flows From Investing Activities | |||||
| Investments Purchased | |||||
| Proceeds from Sale of Investments | |||||
| Distributions of Private Equity Investments | |||||
| Investment Securities: | |||||
| Proceeds from Sales and Maturities of Investment Securities | |||||
| Purchases of Investment Securities | |||||
| Maturity of Certificates of Deposit | |||||
| Purchase of Certificates of Deposit | |||||
| Cash Acquired for Acquisitions, net of Cash Paid | |||||
| Purchase of Furniture, Equipment and Leasehold Improvements | |||||
| Net Cash Provided by (Used in) Investing Activities | |||||
| Cash Flows From Financing Activities | |||||
| Issuance of Noncontrolling Interests | |||||
| Distributions to Noncontrolling Interests | |||||
| Payments Under Tax Receivable Agreement | |||||
| Payment of Notes Payable | |||||
| Issuance of Notes Payable | |||||
| Debt Issuance Costs | |||||
| Purchase of Treasury Stock and Noncontrolling Interests | |||||
| Dividends | |||||
| Net Cash Provided by (Used in) Financing Activities | |||||
| Effect of Exchange Rate Changes on Cash | |||||
| Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash | |||||
| Cash, Cash Equivalents and Restricted Cash – Beginning of Period | |||||
| Cash, Cash Equivalents and Restricted Cash – End of Period | |||||
| SUPPLEMENTAL CASH FLOW DISCLOSURE | |||||
| Payments for Interest | |||||
| Payments for Income Taxes | |||||
| Accrued Dividends | |||||
| Amounts Due for Purchase of Noncontrolling Interest | |||||
| Redemption of Luminis Interest | |||||
| Contingent Consideration Accrued | |||||
| Receipt of Equity Securities in Settlement of Accounts Receivable | |||||
| Settlement of Contingent Consideration | |||||
| Shares Issued as Consideration for Acquisitions | |||||
| Deferred Purchase Price Payable in Shares or Cash for Acquisitions | |||||
| Assets Acquired in Acquisitions | |||||
| Liabilities Assumed in Acquisitions | |||||
Loading...